CN106668241A - External preparation of paederia scandens extract for treating haemorrhoids - Google Patents
External preparation of paederia scandens extract for treating haemorrhoids Download PDFInfo
- Publication number
- CN106668241A CN106668241A CN201710173482.4A CN201710173482A CN106668241A CN 106668241 A CN106668241 A CN 106668241A CN 201710173482 A CN201710173482 A CN 201710173482A CN 106668241 A CN106668241 A CN 106668241A
- Authority
- CN
- China
- Prior art keywords
- external preparation
- extract
- fevervine
- group
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Alternative & Traditional Medicine (AREA)
Abstract
The invention provides an external preparation of a paederia scandens extract for treating haemorrhoids. When the weight ratio of the paederia scandens extract in the external preparation is 10-90%, the external preparation has an obvious therapeutical effect for haemorrhoids; when the weight ratio of the paederia scandens extract in the external preparation is 20-70%, the therapeutical effect for haemorrhoids is stronger. Compared with the prior art, the external preparation of the paederia scandens extract for treating haemorrhoids is simple in preparation, reliable in curative effect and low in cost, and does not have toxicity or side effects, therefore, the external preparation has a very high application value and is suitable for popularization and application.
Description
Technical field
The present invention relates to a kind of fevervine extract external preparation for treating hemorrhoid, for treating hemorrhoid.
Background technology
Hemorrhoid are a kind of commonly encountered diseases, frequently-occurring disease, and main clinical manifestation is to have blood in stool, pain, edema, falling inflation, prurituss, secretions
The symptom such as increase and deviate from, had a strong impact on life, working and learning, so exploitation has the hemorrhoid treating medicine of good result
Thing is significant.
At present the method for the treatment of hemorrhoid mainly has Drug therapy, surgical ligation and injection treatment.Anorectal educational circles of China is clear and definite
Point out that the purpose treated is not to eliminate hemorrhoid body, but eliminate symptom.These treatment concepts make non-operative treatment especially basic medicine
The importance of thing treatment is burst.It is to eliminate symptom, asymptomatic hemorrhoid that the suggestion of present scholar mostly is the therapeutic purposes of hemorrhoid
Without the need for treatment, Symptomatic hemorrhoid more than 90% can Jing non-operative treatment eliminate symptom, only less than 10% hemorrhoid patients need
Surgical intervention.Drug therapy energy reducing swelling and alleviating pain, relief of symptoms, turn avoid the pain of operation and the complication of injection treatment,
So vast majority of people is adapted to adopt Drug therapy.Drug therapy occupies critical role in the treatment of hemorrhoid, Chinese medicine preparation by
In evident in efficacy and low toxicity side effect, extensively by expert and the favorable comment of patient.The Chinese medicine preparation of hemorrhoid is treated on market ointment, bolt
Agent, patch, ointment, lotion, oral formulations etc., manufacturer is also numerous.That what is sold on domestic market mainly has Ma Yinglong
Moschus ZHICHUAN SHUAN, cream, Gangtai Ointment, hemorrhoid-eliminating paste, jiuhua plaster, bear's gall ointment etc..There is heat-clearing and toxic substances removing, detumescence these medicines more
The effects such as pain relieving, removing the necrotic tissue and promoting granulation, but still can improve in anti-inflammatory analgesic effect.
The content of the invention
It is an object of the invention to provide a kind of fevervine extract external preparation of energy effectively treatment hemorrhoid.
A kind of preparation method of the fevervine extract external preparation for treating hemorrhoid, comprises the following steps:
(1)Prepare wash clean and dried fevervine powder 1000g, in being put into decoction kettle, add deionized water, big fire to decoct
30min, then 2h is cooked by slow fire, decocting liquid is filtered, filtrate is collected, dense fluids is concentrated into, add ethanol to reach concentration of alcohol
80%, stand overnight, drying precipitate is collected, obtain 100g extracts.Except containing paederoside, Paederosidie Acid first in extract
Outside fat, also containing other effective ingredient, including flavonoid, iridoidses, sterols, triterpeness etc., such as kaempferol and Cortex querci dentatae
Element and its glycoside, asperuloside etc., work, therefore curative effect is good compared with single component.
(2)Extract is prepared into into suppository or ointment, wherein when the ratio of the weight containing extract is 10-90%, containing fevervine
Glycosides is 0.78-7.02%, and Paederosidie Acid formicester is 0.77-6.93%;With containing extract weight ratio as 20-70% preferably.
The present invention provides the fevervine extract external preparation for the treatment of hemorrhoid, has the effect that compared with prior art:
The present invention is prepared simply, and curative effect reliability has no toxic side effect, and with low cost, therefore, the present invention has very high using value,
It is suitable to popularization and application.
Specific embodiment
Embodiment one
Fat-soluble suppository substrate, it is 10-90% to add fevervine extract to make weight ratio, is poured into after heating and melting in mould, is cooled down
Take out.It is 0.78-7.02% to contain paederoside in through determining suppository, and Paederosidie Acid formicester is 0.77-6.93%.
Embodiment two
Fat-soluble suppository substrate, it is 20-70% to add fevervine extract to make weight ratio, is poured into after heating and melting in mould, is cooled down
Take out.It is 1.56-5.46% to contain paederoside in through determining suppository, and Paederosidie Acid formicester is 1.54-5.39%.
Embodiment three
Emulsifiable paste matrix, it is 10-90% to add fevervine extract to make weight ratio, after mix homogeneously.Contain in through determining emulsifiable paste
Paederoside is 0.78-7.02%, and Paederosidie Acid formicester is 0.77-6.93%.
Example IV
Emulsifiable paste matrix, it is 20-70% to add fevervine extract to make weight ratio, after mix homogeneously.Contain in through determining emulsifiable paste
Paederoside is 1.56-5.46%, and Paederosidie Acid formicester is 1.54-5.39%.
The mice dimethylbenzene antiinflammatory of embodiment five is tested
48 KM mices, male and female half and half, 20 ± 2g of body weight is randomly divided into 4 groups, i.e. model control group, fevervine and extracts by body weight
Thing group (concentration is 20% emulsifiable paste, and dosage is 100mg/), MAYINGLONGZHICHUANGGAO group (dosage is 100mg/), fevervine
Glycosides group(Emulsifiable paste containing paederoside 20%, dosage is 100mg/)12 per group.
Experimental technique:The μ l of dimethylbenzene 20 are taken, each mouse right ear is applied to.Take after 30min each by reagent be uniformly applied to respectively it is little
Mus auris dextra, auris dextra is put to death to after dimethylbenzene 3.5h, and determines the ear method of double differences, and assay method is:Two ears are cut at auricle baseline, is used
8mm card punch lays auricle at the same position of left and right ear, weighs, the ear method of double differences=auris dextra piece weight-left auricle weight.
As a result fevervine extract has obvious antiinflammatory action, and antiphlogistic effects are better than MAYINGLONGZHICHUANGGAO group, paederoside group.
The ear method of double differences of model group is 6.92 ± 1.26, and the ear method of double differences of fevervine extract group is 3.89 ± 1.56, MAYINGLONGZHICHUANGGAO group
The ear method of double differences is 4.77 ± 1.18, and the paederoside group ear method of double differences is 5.97 ± 1.44.
The mice analgesic activity of embodiment six is tested
KM mices 48, male and female half and half, 20 ± 2g of body weight is randomly divided into 4 groups, i.e. model control group, fevervine and extracts by body weight
Thing group (concentration is 20% emulsifiable paste, and dosage is 100mg/), MAYINGLONGZHICHUANGGAO group (dosage is 100mg/), fevervine
Glycosides group(Emulsifiable paste containing paederoside 20%, dosage is 100mg/)12 per group.
Experimental technique:Mice anum administration, with 10mg cotton balls 100mg medicines are stained with, and cotton balls filled in into internal rectum, and daily one
Secondary, continuous three days, 30 minutes after last time administration is finished, rectal wall injected 5% formalin at anus 3.5cm
0.2ml.Writhing number of times in record mice 20 minutes.As a result fevervine extract has obvious analgesic effect, and analgesic effect is better than horse
Should imperial ZHICHUANG GAO group, paederoside group.The writhing number of times of model group is 46.8 ± 11.3, the writhing number of times of fevervine extract group
For 28.9 ± 16.5, MAYINGLONGZHICHUANGGAO group writhing number of times is 35.7 ± 17.4, paederoside group writhing number of times is 41.8 ±
16.3。
The experiment of the rat Oleum Tiglii hemorrhoid model of embodiment seven
48 SD rats (200 ± 20g) are randomly divided into 4 groups, i.e. model control group, fevervine extract group by body weight, and (concentration is
20% emulsifiable paste, dosage is 200mg/), MAYINGLONGZHICHUANGGAO group (dosage is 200mg/), paederoside group(Containing chicken arrow
The emulsifiable paste of rattan glycosides 20%, dosage is 200mg/)12 per group.Administration:Rat carries a few days ago drop rectum with drug, secondary daily,
200mg medicines are stained with cotton balls, cotton balls is filled in into internal rectum, during administration next time, should first check whether internal rectum has cotton balls (if any cotton
Ball should take out).Last time administration should be 2 hours after modeling.
Modeling:Oleum Tiglii is a kind of conventional proinflammatory agent, conventional Oleum Tiglii mixed liquor with 1 part of distilled water, 4 parts of pyridines, 5
Part ether and 10 part of 15% Oleum Tiglii diethyl ether solution are prepared.Oleum Tiglii mixed liquor is stained with 10mg cotton balls, by the cotton balls after immersion
Rat anal is put into, is taken out after stopping 15 seconds.
Index determining:After modeling 7 hours, every rat intravenous injection 1% her Wen orchid normal saline solution (2ml/kg),
Sacrificed by exsanguination animal after 40 minutes, cut-off intestinal and perianal tissue, use acetone normal saline 7 after weighing:3 solution soaking 48 are little
When, 3000rpm is centrifuged 10 minutes, takes supernatant and surveys absorbance in 590nm, as evaluation vascular permeability index,
As a result show, fevervine extract can well reduce the rectum vein permeability of Oleum Tiglii hemorrhoid model mice, curative effect
Better than MAYINGLONGZHICHUANGGAO group, paederoside group.The light absorption value of model group is 0.161 ± 0.026, the suction of fevervine extract group
Light value is 0.111 ± 0.036, and the light absorption value of MAYINGLONGZHICHUANGGAO group is 0.127 ± 0.041, and paederoside group light absorption value is
0.141±0.031。
Claims (3)
1. a kind of fevervine extract external preparation for treating hemorrhoid, it is characterised in that the weight of fevervine extract in preparation
Containing paederoside it is 0.78-7.02% in preparation than for 10-90%, Paederosidie Acid formicester is 0.77-6.93%, is contained in extract
There are flavonoid, iridoidses, sterols, triterpeness etc., such as kaempferol, Quercetin and its glycoside, asperuloside, fevervine
Glycosides, Paederosidie Acid formicester etc., work, therefore curative effect is good compared with single component.
2. fevervine extract external preparation as claimed in claim 1, it is characterised in that the weight of fevervine extract in preparation
It is 1.56-5.46% that amount contains paederoside than being 20-70%, in preparation, and Paederosidie Acid formicester is 1.54-5.39%.
3. the extract external preparation of the fevervine according to described in any of the above-described claim prepares the medicine for the treatment of hemorrhoid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710173482.4A CN106668241A (en) | 2017-03-22 | 2017-03-22 | External preparation of paederia scandens extract for treating haemorrhoids |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710173482.4A CN106668241A (en) | 2017-03-22 | 2017-03-22 | External preparation of paederia scandens extract for treating haemorrhoids |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106668241A true CN106668241A (en) | 2017-05-17 |
Family
ID=58826229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710173482.4A Pending CN106668241A (en) | 2017-03-22 | 2017-03-22 | External preparation of paederia scandens extract for treating haemorrhoids |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106668241A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200044373A (en) * | 2018-10-19 | 2020-04-29 | 호서대학교 산학협력단 | Composition for skin regeneration and wound healing containing absolute of paederia foetida flower |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102846784A (en) * | 2011-06-23 | 2013-01-02 | 宁波大昌药业有限公司 | Paederia scandens water extract, and preparation method and application thereof |
-
2017
- 2017-03-22 CN CN201710173482.4A patent/CN106668241A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102846784A (en) * | 2011-06-23 | 2013-01-02 | 宁波大昌药业有限公司 | Paederia scandens water extract, and preparation method and application thereof |
Non-Patent Citations (1)
Title |
---|
田华咏等: "《土家医方药精选》", 31 January 2014, 中医古籍出版社 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200044373A (en) * | 2018-10-19 | 2020-04-29 | 호서대학교 산학협력단 | Composition for skin regeneration and wound healing containing absolute of paederia foetida flower |
KR102127570B1 (en) | 2018-10-19 | 2020-06-26 | 호서대학교 산학협력단 | Composition for skin regeneration and wound healing containing absolute of paederia foetida flower |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103272041B (en) | A kind of Chinese medicine composition for the treatment of hemorrhoid | |
CN102772712B (en) | Traditional Chinese medicine composition for treating heat-toxicity, flourishing and blood stasis type diabetic foot | |
CN106668241A (en) | External preparation of paederia scandens extract for treating haemorrhoids | |
CN103432497B (en) | External preparation for treating haemorrhoids | |
CN103479970B (en) | External medicine for treating rheumatic arthralgia | |
CN102824570B (en) | Method of preparing traditional Chinese medicine lotion for treating dark urine type closed fracture | |
CN104758726A (en) | Traditional Chinese medicine composition for treating urinary tract infection | |
CN104208295A (en) | Medicine for treating scalds | |
CN103908600A (en) | Externally-applied medicine for treating rheumatoid arthritis damp-heat blockage symptom as well as preparation method and administration method thereof | |
CN107468857A (en) | A kind of Chinese medicinal preparation method that can treat gastric ulcer | |
CN102824563B (en) | Method for preparing Chinese medicinal lotion for treating closed fracture due to frequent micturition and urgent micturition | |
CN102727641B (en) | External traditional Chinese medicine for treating superficial phlebitis | |
CN105616536A (en) | Traditional Chinese medicine liniment for treating leukoderma | |
CN110339281A (en) | A kind of Chinese medicine hemostatic formulations and preparation method thereof | |
CN103768290A (en) | Traditional Chinese medicine composition for treating synovitis and preparation method thereof | |
CN102824546B (en) | Method for preparing traditional Chinese medicinal lotion for treating closed fracture due to deficiency of kidney yin | |
CN107812091A (en) | A kind of Chinese medicine preparation for treating phlebitis caused by chemotherapeutics and preparation method thereof | |
CN105963469A (en) | Traditional Chinese herbal medicine composition for treating haemorrhoids and postoperative complications thereof | |
CN103110737B (en) | Traditional Chinese medicine composition for treating gynecologic inflammation and preparation method thereof | |
CN102579777A (en) | Preparation method of Chinese medicinal lotion for treating chronic ulcer of shank with itching syndrome | |
CN102614357A (en) | Preparation method of traditional Chinese medicine lotion for treating lumbago type lumbago | |
CN103751272B (en) | Treat the Chinese medicine composition and its extract of ankylosing spondylitis | |
CN101390973A (en) | Use of traditional Chinese medicine in preparing medicine for treating retinal vein obstruction | |
CN107551030B (en) | A kind of Chinese medicine composition, preparation and the preparation method of anti-venous thronbosis | |
CN106389702A (en) | Traditional Chinese medicine for recovering symptoms of gynecological and obstetric surgery and preparation method of traditional Chinese medicine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170517 |
|
WD01 | Invention patent application deemed withdrawn after publication |